Literature DB >> 33179770

A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa.

Rob L Shaver1, Gregor B E Jemec2,3, Rebecca Freese4, Afsaneh Alavi5,6, Michelle A Lowes7, Noah Goldfarb8,9.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33179770      PMCID： PMC8106619          DOI： 10.1111/ijd.15295

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   3.204


× No keyword cloud information.
  5 in total

1.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

2.  Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

Authors:  L Thorlacius; A Garg; P T Riis; S M Nielsen; V Bettoli; J R Ingram; V Del Marmol; L Matusiak; J C Pascual; J Revuz; K Sartorius; T Tzellos; H H van der Zee; C C Zouboulis; D M Saunte; A B Gottlieb; R Christensen; G B E Jemec
Journal:  Br J Dermatol       Date:  2019-06-06       Impact factor: 9.302

Review 3.  Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.

Authors:  T V Nguyen; G Damiani; L A V Orenstein; I Hamzavi; G B Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-16       Impact factor: 6.166

4.  Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa.

Authors:  N Goldfarb; J R Ingram; G B E Jemec; H B Naik; V Piguet; M J Hyde; R Freese; M A Lowes; A Alavi
Journal:  Br J Dermatol       Date:  2019-09-17       Impact factor: 9.302

Review 5.  Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.

Authors:  J R Ingram; S Hadjieconomou; V Piguet
Journal:  Br J Dermatol       Date:  2016-05-02       Impact factor: 11.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.